CTI 112 Pill - white oval, 15mm
Pill with imprint CTI 112 is White, Oval and has been identified as Acyclovir 400 mg. It is supplied by Carlsbad Technology, Inc.
Acyclovir is used in the treatment of Cold Sores; Herpes Simplex; Herpes Simplex Encephalitis; Herpes Simplex - Congenital; Herpes Simplex, Suppression and belongs to the drug class purine nucleosides. There is no proven risk in humans during pregnancy. Acyclovir 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CTI 112
Acyclovir
- Imprint
- CTI 112
- Strength
- 400 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Purine nucleosides
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Carlsbad Technology, Inc.
- Inactive Ingredients
-
corn starch,
microcrystalline cellulose,
magnesium stearate,
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 61442-0112 | Carlsbad Technology, Inc. |
| 42291-0108 (Discontinued) | AvKare, Inc. |
| 63739-0682 (Discontinued) | McKesson Packaging Services |
Related images for "CTI 112"
More about acyclovir
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (186)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: purine nucleosides
- Breastfeeding
Patient resources
- Acyclovir drug information
- Acyclovir injection
- Acyclovir (Buccal mucosa) (Advanced Reading)
- Acyclovir (Oral, Intravenous) (Advanced Reading)
- Acyclovir Buccal Tablets
Other brands
Professional resources
- Acyclovir monograph
- Acyclovir Capsules (FDA)
- Acyclovir IV Infusion (FDA)
- Acyclovir Injection (FDA)
- Acyclovir Oral Suspension (FDA)
- Acyclovir Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
